1. Informed consent /Enrollment: Women will be approached by trained study staff in the third trimester or when they present for delivery and asked if they wish to participate in the study. Women who meet the study's eligibility criteria and agree to participate will be asked to provide written consent. After enrollment, their baseline data will be recorded and a pre-delivery hemoglobin assessment will be done.